ArticleAdvances in therapy2023

Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.

Jacob P Thyssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.